BACKGROUND AND PURPOSE: regaining functional independence is an important goal for people who have experienced stroke. We hypothesized that introducing earlier and more intensive out-of-bed activity after stroke would reduce time to unassisted walking and improve independence in activities of daily living. METHODS: a Very Early Rehabilitation Trial (AVERT) was a phase II randomized controlled trial. Patients with confirmed stroke (infarct or hemorrhage) admitted <24 hours after stroke and who met physiological safety criteria were eligible. Patients randomized to the very early and intensive mobilization group were mobilized within 24 hours of stroke and at regular intervals thereafter. Control patients received standard stroke unit care. The primary outcome for this analysis was the number of days required to return to walking 50 m unassisted. Secondary outcomes were the Barthel Index and Rivermead Motor Assessment at 3 and 12 months after stroke. RESULTS:seventy-one stroke patients with a mean age of 74.7 years were recruited from 2 hospitals. Adjusted Cox regression indicated that very early and intensive mobilization group patients returned to walking significantly faster than did standard stroke unit care controls (P=0.032; median 3.5 vs 7.0 days). Multivariable regression revealed that exposure to very early and intensive mobilization was independently associated with good functional outcome on the Barthel Index at 3 months (P=0.008) and on the Rivermead Motor Assessment at 3 (P=0.050) and 12 (P=0.024) months. CONCLUSIONS: earlier and more intensive mobilization after stroke may fast-track return to unassisted walking and improve functional recovery. Clinical Trial Registration- This trial was not registered because enrollment began before July 2005.
RCT Entities:
BACKGROUND AND PURPOSE: regaining functional independence is an important goal for people who have experienced stroke. We hypothesized that introducing earlier and more intensive out-of-bed activity after stroke would reduce time to unassisted walking and improve independence in activities of daily living. METHODS: a Very Early Rehabilitation Trial (AVERT) was a phase II randomized controlled trial. Patients with confirmed stroke (infarct or hemorrhage) admitted <24 hours after stroke and who met physiological safety criteria were eligible. Patients randomized to the very early and intensive mobilization group were mobilized within 24 hours of stroke and at regular intervals thereafter. Control patients received standard stroke unit care. The primary outcome for this analysis was the number of days required to return to walking 50 m unassisted. Secondary outcomes were the Barthel Index and Rivermead Motor Assessment at 3 and 12 months after stroke. RESULTS: seventy-one strokepatients with a mean age of 74.7 years were recruited from 2 hospitals. Adjusted Cox regression indicated that very early and intensive mobilization group patients returned to walking significantly faster than did standard stroke unit care controls (P=0.032; median 3.5 vs 7.0 days). Multivariable regression revealed that exposure to very early and intensive mobilization was independently associated with good functional outcome on the Barthel Index at 3 months (P=0.008) and on the Rivermead Motor Assessment at 3 (P=0.050) and 12 (P=0.024) months. CONCLUSIONS: earlier and more intensive mobilization after stroke may fast-track return to unassisted walking and improve functional recovery. Clinical Trial Registration- This trial was not registered because enrollment began before July 2005.
Authors: Martin Wieser; Stefan Gisler; Amirehsan Sarabadani; Rafael M Ruest; Lilith Buetler; Heike Vallery; Verena Klamroth-Marganska; Margret Hund-Georgiadis; Morena Felder; Josef L Schoenberger; Clemens Gutknecht; Robert Riener Journal: Med Biol Eng Comput Date: 2013-10-07 Impact factor: 2.602
Authors: Anna E Mattlage; Sara A Redlin; Michael A Rippee; Michael G Abraham; Marilyn M Rymer; Sandra A Billinger Journal: J Neurol Phys Ther Date: 2015-07 Impact factor: 3.649
Authors: Amirehsan Sarabadani Tafreshi; Jan Okle; Verena Klamroth-Marganska; Robert Riener Journal: Med Biol Eng Comput Date: 2017-02-10 Impact factor: 2.602
Authors: Andrew N Clarkson; Kim Parker; Michael Nilsson; F Rohan Walker; Emma K Gowing Journal: J Cereb Blood Flow Metab Date: 2015-03-11 Impact factor: 6.200
Authors: Rebekah A Yataco; Scott M Arnold; Suzanne M Brown; W David Freeman; C Carmen Cononie; Michael G Heckman; Luke W Partridge; Craig M Stucky; Laurie N Mellon; Jennifer L Birst; Kristien L Daron; Martha H Zapata-Cooper; Danton M Schudlich Journal: Neurocrit Care Date: 2019-04 Impact factor: 3.210